Previous Article | Next Article ![]()
Molecular and Cellular Biology, November 2008, p. 6620-6631, Vol. 28, No. 21
0270-7306/08/$08.00+0 doi:10.1128/MCB.00448-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science, 2641 Yamazaki, Noda-shi Chiba-ken, 278-8510, Japan,1 Department of Pharmacology, Hillman Cancer Center, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania 15213-18632
Received 19 March 2008/ Returned for modification 24 April 2008/ Accepted 20 August 2008
|
|
|---|
|
|
|---|
Schizosaccharomyces pombe Cid1 and Cid13 are cytoplasmic noncanonical PAPs. Cid1 is required for the S-M checkpoint control, including migration from mitosis to meiosis (47), while Cid13 participates in DNA replication and genome maintenance by specifically regulating suc22 mRNA, which encodes a subunit of ribonucleotide reductase (39). In addition, very recent studies have shown that Cid1 has poly(U) polymerase activity in addition to PAP activity (24, 36). Caenorhabditis elegans GLD-2, initially identified as a gene involved in the control of germ line development, is a cytoplasmic noncanonical PAP that promotes the transition from mitosis to meiosis. GLD-2 enzyme activity is stimulated by forming a heterodimeric PAP with an RNA-binding protein GLD-3 (45). Subsequently, GLD-2 homologues were identified in vertebrates, including frogs, mice, and humans. Vertebrate GLD-2 proteins are important for meiotic maturation of oocytes and are probably involved in the activation of many mRNAs throughout early development (37). In addition, it has been suggested that mammalian GLD-2 are responsible for localized cytoplasmic polyadenylation of neuronal mRNAs at synapses (52). Hs4, one of the human noncanonical PAPs (Hs1-Hs5), was identified as the mitochondrial PAP (hmtPAP) required for mitochondrial RNA polyadenylation (31, 42).
In S. cerevisiae, Trf4 and its redundant homologue Trf5 were identified as nuclear noncanonical PAPs (9, 14, 16). These proteins were initially reported to possess DNA polymerase activity in vitro and were classified as the fourth essential DNA polymerase, DNA polymerase
(48, 49). Unlike cytoplasmic noncanonical PAPs, Trf4 functions in a nuclear RNA surveillance pathway as part of the TRAMP complex, which activates RNA for exosome-mediated degradation by the addition of a poly(A) tail (9, 20, 21, 25, 43, 53). Trf4 interacts with an RNA helicase (Mtr4) and one of two functionally redundant putative RNA-binding proteins (Air1 or Air2) to form the Trf4/Air1/Mtr4 polyadenylation (TRAMP) complex. This mechanism resembles the role of polyadenylation in bacterial RNA turnover (6, 8, 22, 27, 32). Recent studies show that Trf4 is involved in the regulation of histone mRNA levels for the maintenance of genome stability (35). Furthermore, Trf4 is responsible for the control of the ribosomal DNA (rDNA) copy number by degradation of cryptic transcripts from telomeric and rDNA spacer regions (15). In S. pombe, Cid14 has been identified as the functional homologue of Trf4 and Trf5. It appears that this enzyme polyadenylates pre-rRNAs to trigger RNA processing by the exosome (51). In addition, Cid14 is also involved in the elimination of a variety of RNA targets to regulate heterochromatic gene silencing, meiotic differentiation, and maintenance of genomic integrity (2, 46). A similar polyadenylation-mediated degradation was observed in the catabolism of pre-mRNAs in human cells, but the PAP involved in the pathway is still obscure (50).
The 3'-5' exonuclease Rrp6, a constituent of the exosome, plays a key role in nuclear exosome-dependent degradation (30). S. cerevisiae strains lacking Rrp6 accumulate polyadenylated snRNAs, snoRNAs, and rRNAs in a ScTrf4-dependent manner (53). These findings suggest that the noncoding RNAs, such as snRNAs, snoRNAs, and rRNAs, are the main targets of ScTrf4 during polyadenylation-mediated degradation.
The process of mRNA splicing is a major posttranscriptional event that is essential for the maturation of mRNAs in eukaryotes. The reaction is accomplished by spliceosomes, which primarily consist of RNA-protein complexes called small nuclear ribonucleoproteins (snRNPs). The snRNPs contain U1, U2, U4, U5, and U6 small nuclear RNAs (snRNAs) and bind to the pre-mRNA in a specific order to align the splice sites for cleavage. First, the U1 and U2 snRNPs bind to the 5' end of the intron and the branch site close to the 3' end of the intron, respectively, generating the prespliceosome. Then, the preformed U4/U6-U5 tri-snRNP, in which the U4 and U6 snRNAs are base paired, join the complex and form the mature spliceosome. The mature spliceosome induces a major structural change that results in the dissociation of the U1 and U4 snRNPs, allowing U6 snRNP to interact with sequences close to the 5' splice site and U5 snRNP interacts with nucleotides at the end of the first exon, just before the 5' splice junction. This is the active spliceosome, which catalyzes 5' cleavage and lariat formation. U5 snRNP remains attached to the end of the first exon and also begins to interact with the beginning of the second exon, thus bringing the two exons together. The ligated exons are released from the spliceosome, but the lariat intron remains bound. The spliceosome then disassembles, releasing the lariat, which is linearized and degraded. The snRNPs are subsequently recycled (19, 28).
Although the Trf4 family of proteins is conserved from yeast to humans, their biological role in multicellular organisms is poorly understood. We analyzed here the biological roles of Drosophila Trf4 homologs (DmTRF4). Our data suggest that in addition to ScTrf4/5 one DmTRF4 is also involved in the RNA surveillance system.
|
|
|---|
P-element insertion mutant for the CG17462 gene, CG17462NP2505, and for the DmRrp6 gene, DmRrp6f07001, were obtained from the Drosophila Genetic Resource Center, Kyoto Institute of Technology (Kyoto, Japan) and the Exelixis Collection at the Harvard Medical School (Boston, MA), respectively.
Establishment of transgenic flies. The pUAS-DmTRF4-1 was constructed from the entire open reading frame of DmTRF4-1. This was achieved by PCR using the primer pair PM01/PM02 (Table 1) with cDNA (EST clone RE04457) as a template. The amplified product was then subcloned into pUAST transformation vector. The pUAS-Dmtrf4-1 IR was constructed from nucleotides 1540 to 2015 of DmTRF4-1 cDNA cloned into pUAST as an inverted repeat with an interruption of the DmTRF4-1 third intron. The PCR was performed using cDNA and genome-DNA as a template with the primer pairs PM05-PM06 and PM07-PM08, respectively (Table 1). The two amplified products were then subcloned into pUAST vector in a head-to-head orientation. P-element transformation was performed by using a standard method. Several independent lines were established for the pUAS-DmTRF4-1 and pUAS-Dmtrf4-1 IR, respectively. All crosses were performed at 28°C, except crossing Hsp70-GAL4.
|
View this table: [in a new window] |
TABLE 1. Oligonucleotide sequences used in this study
|
Northern blotting, for the experiments shown in Fig. 1, was carried out as described previously (41). Full-length DmTRF4-1 or -2 was used as the specific probe. Full-length ribosomal protein 49 (Rp49) cDNA was used as a control. For the experiments shown in Fig. 7, RNA [5 µg of total RNA, 1 µg of purified poly(A)+ RNA, and 1 µg of deadenylated RNA] was separated in a 6% polyacrylamide gel (19:1) containing 8 M urea, electrophoretically transferred to nylon membrane (Hybond-N+; Amersham) in 0.5x TBE (1x TBE is 89 mM Tris-borate and 2 mM EDTA) at 3.3 mA/cm2 for 2 h, and then UV cross-linked to the membrane by using Stratalinker (Stratagene, La Jolla, CA). Membranes were hybridized in ULTRAhyb-Oligo (Ambion, Austin, TX) using oligonucleotide DNA probes (Table 1) that were 5' end labeled using T4 polynucleotide kinase (TaKaRa Bio) and [
-32P]ATP (GE Healthcare Bioscience, Piscataway, NJ). After two washes in 2x SSC (1x SSC is 0.15 M NaCl, 0.015 M sodium citrate [pH 7.0]) plus 0.5% sodium dodecyl sulfate, the membrane was exposed to BioMax MS-1 (Kodak, Rochester, NY).
![]() View larger version (60K): [in a new window] |
FIG. 1. DmTRF4-1 and DmTRF4-2 are candidate genes for the homologue of S. cerevisiae Trf4/5. (A) Schematic representation of DmTRF4-1, DmTRF4-2, and ScTrf4. The location of the nucleotidyltransferase domain and the PAP-associated domain are indicated by dark gray and light gray boxes, respectively. Numbers to the right of the boxes indicate the total number of amino acids in the respective proteins. Homology/similarity (as a percentage) in the catalytic domains between DmTRF4-1 or DmTRF4-2 and ScTrf4 are indicated below each box, respectively. (B) Comparison of DmTRF4-1, DmTRF4-2, and ScTrf4. An amino acid alignment of the catalytic domain, consisting of the nucleotidyltransferase domain and the PAP-associated domain, of DmTRF4-1, DmTRF4-2, and ScTrf4. Identical and similar amino acid residues are boxed in black and gray, respectively. The two conserved catalytic aspartate residues are indicated by asterisks. The alignment was carried out using the CLUSTAL W program. (C) Expression of DmTRF4-1 and DmTRF4-2 during the Drosophila development. Northern blotting was successively performed on the same membrane. A portion (30 µg) of total RNA was applied to each lane. Rp49 mRNA served as a loading control.
|
![]() View larger version (54K): [in a new window] |
FIG. 7. Overexpression of DmTRF4-1 causes extraordinary snRNA polyadenylation, which is DmRrp6 dependent. Total RNA (5 µg) (total; left panels), purified poly(A)+ RNA (1 µg) [poly(A)+; middle panels], deadenylated RNA (1 µg) [poly(A)–; right panels] were isolated from third-instar larvae of Hsp70-GAL4/+ (control; lanes 1, 7, and 13), Hsp70-GAL4/+; DmRrp6f07001/+ (DmRrp6 KD; lanes 2, 8, and 14), Hsp70-GAL4/UAS-Dmtrf4-1 IR (DmTRF4-1 KD; lanes 3, 9, and 15), Hsp70-GAL4/UAS-Dmtrf4-1 IR; DmRrp6f07001/+ (DmTRF4-1 KD and DmRrp6 KD; lanes 4, 10, and 16), Hsp70-GAL4/+; UAS-DmTRF4-1/+ (DmTRF4-1 OE; lanes 5, 11, and 17), Hsp70-GAL4/+; UAS-DmTRF4-1/DmRrp6f07001 (DmTRF4-1 OE and DmRrp6 KD; lanes 6, 12, and 18) after induction of GAL4 expression by heat shock for 3 h. Specific radiolabeled probes (Table 1) for U1 (A), U2 (B), U4 (C), U5 (D), U6 (E), snRNA and Ribosomal protein S29 (RpS29), as a loading control (F), were hybridized and detected by autoradiography. The migration positions of the regular snRNA and polyadenylated snRNA are indicated on the right of the panels. The ratio of the polyadenylated snRNAs in Hsp70-GAL4/+; UAS-DmTRF4-1/DmRrp6f07001 (DmTRF4-1 OE and DmRrp6 KD) to those in Hsp70-GAL4/+; UAS-DmTRF4-1/+ (DmTRF4-1 OE) are shown in lane 12. Each band intensity was quantified by using a BAS-3000 imaging analyzer and normalized to RpS29 mRNA.
|
![]() View larger version (33K): [in a new window] |
FIG. 3. DmTRF4-1 knockdown and DmTRF4-2 knockout mutants. (A) Physical map of the genomic location of DmTRF4-2 (CG17462). In CG17462NP2505, P-element was inserted in the 5'-untranslated region of the CG17462 gene. Black and gray arrows indicate predicted genes. (B) RT-PCR was performed for total RNAs from WT (lane 1) and DmTRF4-2 mutant (CG17462NP2505; lane 2) third-instar larvae. Expression of Act5C was used as an internal control. The cycle numbers used are indicated. (C) RT-PCR was performed for total RNAs from Act5c-GAL4/+ (control; lane 1) and Act5C-GAL4/UAS-Dmtrf4-1 IR (DmTRF4-1 KD; lane 2) third-instar larvae. Expression of Act5C was used as an internal control. The cycle numbers are indicated. The relative amount of the DmTRF4-1 transcript in Act5c-GAL4/UAS-DmTRF4-1 IR to that in Act5C-GAL4/+, normalized to Act5C mRNA, was also quantified graphically. The data represent the mean of three independent measurements. Error bars indicate ± the standard deviation. (D) Knockdown of the DmTRF4-1 level by ubiquitous expression of the DmTRF4-1 double-stranded RNAs in living flies (Act5C-GAL4/UAS-Dmtrf4-1 IR) caused third-instar-larval or early pupal lethality. Few transgenic flies survived until the late pupal stage, but when this happened the body of the pupa was significantly darkened. Note the darkened imaginal body in the DmTRF4-1 knockdown mutant, as indicated by the arrowhead (DmTRF4-1 KD; panel a). Early pupal lethality was not observed in control flies (Act5C-GAL4/+) (Control; panel b).
|
![]() View larger version (72K): [in a new window] |
FIG. 5. Effects of overexpression of the DmTRF4-1 in D. melanogaster. (A) RT-PCR was performed for total RNAs from Hsp70-GAL4/+ (control; lane 1), Hsp70-GAL4/UAS-Dmtrf4-1 IR (DmTRF4-1 KD; lane 2), Hsp70-GAL4/+; UAS-DmTRF4-1/+ (DmTRF4-1 OE; lane 3), and Hsp70-GAL4/UAS-Dmtrf4-1 IR; UAS-DmTRF4-1/+ (DmTRF4-1 KD and OE; lane 4) third-instar larvae incubated for 3 h at 37°C. Expression of Act5C was used as an internal control. The cycle numbers are indicated. The relative amount of the DmTRF4-1 transcript in each sample to that in Hsp70-Gal4/+, normalized to Act5C mRNA, was also quantified graphically. The data represent the mean of three independent measurements. Error bars indicate + the standard deviation. (B) The transgenic fly lines crossed the GMR-GAL4 driver, which induced GAL4 posterior to the MF of the eye disc. No phenotype were observed in control flies (GMR-GAL4/+; +; +) (control; panel a) and knockdown flies DmTRF4-1(GMR-GAL4/+; UAS-Dmtrf4-1 RI/+; +) (DmTRF4-1 KD; panel b). Overexpression of the DmTRF4-1 caused a rough eye phenotype (GMR-GAL4/+; +; UAS-DmTRF4-1/+), as indicated by the arrowhead (DmTRF4-1 OE; panel c). Knockdown of the DmTRF4-1, while overexpressing DmTRF4-1, suppressed a rough eye phenotype induced by overexpression of the DmTRF4-1 (GMR-GAL4/+; UAS-Dmtrf4-1 RI/+; UAS-DmTRF4-1/+) (DmTRF4-1 KD and OE; panel d). (C) Overexpression of DmTRF4-1 in the wing imaginal disc using the MS1096-GAL4 driver caused an underdeveloped wing (MS1096-GAL4/+; +; UAS-DmTRF4-1/+), as indicated by the arrowhead (DmTRF4-1 OE; panel a). No phenotype was observed in control flies (MS1096-GAL4/+) (control; panel b). (D) Overexpression of DmTRF4-1 in the whole eye imaginal disc using the ey-GAL4 driver resulted in a headless phenotype, as indicated by the arrowhead, and caused lethality at the pupal stage (ey-GAL4/+; UAS-DmTRF4-1/+) (DmTRF4-1 OE; panel a). No phenotype was observed in control flies (ey-GAL4/+) (control; panel b). These were the contents of the dissected pupa.
|
![]() View larger version (44K): [in a new window] |
FIG. 6. DmRrp6 mutant suppresses a rough eye phenotype induced by the overexpression of DmTRF4-1. (A) Physical map of the genomic location of DmRrp6. In DmRrp6f07001, the P-element was inserted in the second intron of the DmRrp6 gene. Black and gray arrows indicate predicted genes. (B) RT-PCR was performed for total RNAs from WT (lane 1) and DmRrp6 mutant (DmRrp6f07001; lane 2) third-instar larvae. A homozygote of the DmRrp6f07001 is inviable. Expression of Act5C was used as an internal control. The cycle numbers used are indicated. The relative amount of the DmRrp6 transcript in DmRrp6f07001 to that in the WT, normalized to Act5C mRNA, was also quantified graphically. The data represent the mean of three independent measurements. Error bars indicate ± the standard deviation. (C) DmRrp6 mutation suppresses the phenotype induced by overexpression of DmTRF4-1. No phenotype was observed in the WT fly (control; panel a) and DmRrp6 mutant (DmRrp6f07001) (DmRrp6 KD; panel b). Overexpression of DmTRF4-1 posterior to the MF of the eye disc caused a rough eye phenotype (GMR-GAL4/+; +; UAS-DmTRF4-1/+) (DmTRF4-1 OE; panel c). DmRrp6 mutation slightly suppressed the rough eye phenotype induced by overexpression of DmTRF4-1 (GMR-GAL4/+; +; UAS-DmTRF4-1/DmRrp6f07001) (DmTRF4-1 OE and DmRrp6 KD; panel d). Note that the rough eye phenotype is indicated by arrowheads.
|
The DmTRF4-1 mutant (GST-DmTRF4-1 DD328,330AA) was overexpressed and purified as for the WT protein.
PAP assay. PAP assays were performed in 20-µl reaction mixtures containing 250 to 500 ng of the purified protein, 2.5 fmol of 5'-end-labeled oligo(A)15, 0.5 mM ATP, 0.5 mM MnCl2, 25 mM Tris-HCl (pH 7.9), 20 mM KCl, 10% glycerol, 0.01 mM EDTA, 0.1 mg of BSA/ml, 1 mM dithiothreitol, 0.02% Nonidet P-40, and 5 U of RNA Guard (Promega). As indicated in the figure legends, in some experiments we modified the components of the above reaction in the following ways: 5 mM MgCl2 replaced MnCl2 (see Fig. 2C, lanes 2 and 6); both 0.5 mM MnCl2 and 5 mM MgCl2 were added at the same time (see Fig. 2C, lanes 4 and 8); and the reaction mixture contained 0.5 mM concentrations of either GTP, UTP, or CTP instead of ATP (see Fig. 2D). Assay mixtures were assembled on ice and incubated at 30°C for the times indicated and stopped by the addition of loading buffer (20 µl) containing 95% formamide, 0.025% bromophenol blue, 0.025% xylene cyanol FF, and 0.5 mM EDTA. The reaction products were resolved on 20% polyacrylamide gels containing 8 M urea. After drying, the gel was exposed to BioMax MS-1 film (Kodak).
![]() View larger version (37K): [in a new window] |
FIG. 2. DmTRF4-1, but not DmTRF4-2, exhibits PAP activity. (A) Purified GST fusion protein containing WT DmTRF4-1 (GST-DmTRF4-1 WT; lane 1) and mutant DmTRF4-1 (GST-DmTRF4-1 DD328,330AA; lane 2), in which aspartate residues at positions 328 and 330 have been changed to alanine, and WT DmTRF4-2 (GST-DmTRF4-2 WT; lane 3) were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis on a 7.5 or 12.5% polyacrylamide gel and stained with Coomassie brilliant blue (1.0 µg of each). The positions of the purified proteins are indicated by an asterisk. (B) DmTRF4-1 has PAP activity, but DmTRF4-2 has no activity in vitro. GST-DmTRF4-1 WT (lane 2 to 3) (250 ng), GST-DmTRF4-1 DD328,330AA (lane 4) (500 ng), and GST-DmTRF4-2 WT (lane 5 to 6) (350 ng) were incubated with 5'-end-labeled oligo(A)15 in the presence of 0.5 mM Mn2+ at 30°C. A control reaction with no enzyme is shown in lane 1. (C) Mg2+ versus Mn2+ dependence. GST-DmTRF4-1 WT (250 ng) was incubated with 5'-end-labeled oligo(A)15 in the presence of either Mg2+ (5 mM; lane 2), Mn2+ (0.5 mM; lane 3), or both Mg2+ and Mn2+ ions (5 and 0.5 mM, respectively; lane 4) at 30°C for 30 min. GST-DmTRF4-2 WT (350 ng) was incubated with 5'-end-labeled oligo(A)15 in the presence of either Mg2+ (5 mM; lane 6), Mn2+ (0.5 mM; lane 7), or both Mg2+ and Mn2+ ions (5 and 0.5 mM, respectively; lane 8) at 30°C for 30 min. A control reaction with no cations is shown in lanes 1 and 5. (D) Nucleotide substrate dependence. GST-DmTRF4-1 WT (250 ng) was incubated with 5'-end-labeled oligo(A)15 in the presence of either ATP (lane 1), GTP (lane 2), CTP (lane 3), or UTP (lane 4) at 30°C for 30 min. All PAP polymerase reaction products were resolved on a 20% polyacrylamide-8 M urea gels and visualized by using autoradiography.
|
Immunofluorescence analysis. S2 cells were placed on poly-(L-lysine)-coated coverslips and fixed with 4% paraformaldehyde in NaCl/Pi for 10 min at room temperature. After several washes with NaCl/Pi, the cells were treated with methanol for permeabilization. The samples were incubated with primary antibodies, mouse monoclonal anti-V5 antibody (Invitrogen) and rabbit polyclonal antifibrillarin antibody (Abcam, Cambridge, MA) (used as a nucleolar marker), at 4°C overnight and then treated for 1 h with the secondary antibodies Alexa546 anti-mouse immunoglobulin G and Alexa488 anti-rabbit immunoglobulin G (Molecular Probes, Eugene, OR). Samples were also counterstained with DAPI (4',6'-diamidino-2-phenylindole). The preparations were observed under a fluorescence microscope, and the data were collected using a charge-coupled device camera (Nikon, Chiyoda, Japan).
Oligonucleotides. The oligonucleotide sequences used in the present study as primers and probes are shown Table 1.
|
|
|---|
DmTRF4-1, but not DmTRF4-2, exhibits PAP activity in vitro. To test whether DmTRF4-1 and DmTRF4-2 possess PAP activity, we induced expression of a glutathione S-transferase (GST) fusion protein containing DmTRF4-1 and DmTRF4-2 with a 3' terminal His tag (GST-DmTRF4-1 and GST-TRF4-2) in Escherichia coli. Soluble GST-DmTRF4-1 and -2 were purified on Ni-NTA agarose and glutathione-Sepharose columns (Fig. 2A, lanes 1 and 3). Purified GST-DmTRF4-1 displayed PAP activity (Fig. 2B, lanes 2 to 3). To confirm the absence of E. coli PAP enzymes, we constructed a DmTRF4-1 inactive mutant (GST-DmTRF4-1 DD328,330AA) in which the aspartate residues 328 and 330 were replaced with alanine (Fig. 1B). These residues correspond to the conserved amino acids essential for catalysis in many polymerase β families (29). The GST-DmTRF4-1 DD328,330AA was expressed and purified by the same procedures as for the WT protein (Fig. 2A, lane 2). The GST-DmTRF4-1 DD328,330AA showed no PAP activity (Fig. 2B, lane 4), indicating that GST-DmTRF4-1 protein was responsible for the enzyme activity and not a coprecipitating contaminant. GST-DmTRF4-1 requires Mn2+ for its PAP activity rather than Mg2+ (Fig. 2C, lanes 1 to 4). Furthermore, GST-DmTRF4-1 showed a high degree of selectivity for ATP incorporation into poly(A) RNA, whereas GTP, CTP, and UTP were incorporated very poorly (Fig. 2D). GST-DmTRF4-2 displayed no PAP activity in the presence of either Mn2+ or Mg2+ (see Fig. 2B, lanes 5 to 6; Fig. 2C, lanes 5 to 8).
Although it was initially reported that ScTrf4 is inactive in the absence of accessory proteins (25, 43, 53), a recent study showed that Trf4 and Trf5 exhibit significant PAP activity in isolation (14). Similarly, GST-DmTRF4-1 does not require any accessory proteins for PAP activity in vitro.
DmTRF4-1, but not DmTRF4-2, is essential for development in D. melanogaster.
We searched for disruption mutants in the Gal4 Enhancer Trap Insertion Database (GETDB [http://flymap.lab.nig.ac.jp/
dclust/getdb.html]). The DmTRF4-1 knockout mutant was not stocked, but a strain with a disrupted DmTRF4-2 was found. In this mutant, CG17462NP2505, the P element was inserted in the 5'-untranslated region of the DmTRF4-2 (CG17462) gene (Fig. 3A). We performed semiquantitative PT-PCR and confirmed that CG17462NP2505 was a null mutant of DmTRF4-2 (Fig. 3B). The CG17462NP2505 homozygous mutants were viable and fertile despite lacking DmTRF4-2, indicating that DmTRF4-2 is not essential for viability. To address the in vivo function of DmTRF4-1, we established transgenic fly lines carrying UAS-Dmtrf4-1 IR, which causes an RNA interference-induced knockdown of the DmTRF4-1 transcript when crossing a GAL4 driver (Fig. 3C and 5A). The ubiquitous knockdown of DmTRF4-1 driven by Act5C-GAL4 caused third-instar-larval or early pupal lethality (Fig. 3D), which is reminiscent of trf4 trf5 double mutants (5). These results indicate that DmTRF4-1 is essential for development in D. melanogaster and that DmTRF4-2 is unable to complement DmTRF4-1.
Our experiments using the recombinant proteins and the transgenic flies suggested that DmTRF4-1, like ScTrf4/5, might play a crucial role in RNA quality control. In contrast, DmTRF4-2 appears to be inessential, although we cannot rule out the possibility that the protein is also involved in the same pathway. Therefore, we focused on the characterization of DmTRF4-1 in the present study.
DmTRF4-1 is a nucleolar protein. To investigate the subcellular localization of DmTRF4-1, we attempted to generate Schneider 2 (S2) cells expressing V5-tagged DmTRF4-1 WT under the control of an Actin5C promoter. Unfortunately, we were unable to obtain the desired cell line. This was probably caused by the high-level expression of V5-tagged DmTRF4-1 WT being toxic to S2 cells. We then attempted to visualize the subcellular localization of V5-tagged DmTRF4-1 DD328, 330AA mutant by using immunofluorescence microscopy. We found that DmTRF4-1 DD328,330AA overlapped with the nucleolar marker, fibrillarin (Fig. 4), suggesting that the DmTRF4-1 is a nucleolar protein. It is widely thought that Trf4 family members are nuclear protein (44). However, our findings are consistent with the recent observation that S. pombe Cid14 is a nuclear protein enriched in the nucleolus (51).
![]() View larger version (10K): [in a new window] |
FIG. 4. Subcellular localization of DmTRF4-1 in living S2 cells. The S2 cells overexpressing V5-tagged DmTRF4-1 DD328,330AA was immunostained with anti-V5 antibody (red) (A and A') and antifibrillarin (green) (B and B'), as a nucleolar marker, and stained with DAPI (blue) (C and C'). The merge is shown in (D and D'). The lower panels are a high-magnification view.
|
Previous studies demonstrated that the RNAs polyadenylated by ScTrf4 are exposed to exosome-mediated degradation (9, 20, 21, 25, 43, 53). Rrp6, a 3'-5' exonuclease, plays a key role in this degradation machinery (30). The homozygote of the DmRrp6f07001, where the P-element is inserted into the second intron of the DmRrp6 gene (Fig. 6A), is inviable. The heterozygote of the DmRrp6f07001 expressed approximately half the amount of DmRrp6 transcript compared to the WT (Fig. 6B). We crossed the flies overexpressing DmTRF4-1 with the DmRrp6 mutant. A rough eye phenotype caused by overexpression of DmTRF4-1 was partially rescued in the DmRrp6 heterozygous background, whereas DmRrp6 heterozygous mutants displayed no rough eye phenotype (Fig. 6C).
Overexpression of DmTRF4-1 caused accumulation of polyadenylated snRNAs. It is possible that an aberrant polyadenylation of RNA substrates by DmTRF4-1 interferes with the morphogenetic process. To address this possibility, we examined the polyadenylation of RNAs from third-instar larvae of W (control), heterozygous DmRrp6f07001 (DmRrp6 KD), UAS-Dmtrf4-1 IR (DmTRF4-1 KD), UAS-Dmtrf4-1 IR and heterozygous DmRrp6f07001 (DmTRF4-1 KD and DmRrp6 KD), UAS-DmTRF4-1 (DmTRF4-1 OE), UAS-DmTRF4-1, and heterozygous DmRrp6f07001 (DmTRF4-1 OE and DmRrp6 KD) lines crossed with the Hsp70-GAL4 driver. Polyadenylated RNAs were purified from total RNAs using oligo(dT)-immobilized beads [poly(A)+ RNA fraction]. We found that the band mobility of snRNAs was shifted up to approximately 500 nucleotides in the poly(A)+ RNA fraction from the transgenic flies overexpressing DmTRF4-1 (DmTRF4-1 OE) and DmTRF4-1 in the heterozygous DmRrp6f07001 background (DmTRF4-1 OE and DmRrp6 KD) (Fig. 7A to E, middle panels, lanes 11 and 12). In addition, an increase in the elongated snRNAs (1.6- to 2.5-fold) was observed in the DmTRF4-1 OE and DmRrp6 KD compared to that in the DmTRF4-1 OE. We next treated the poly(A)+ RNA fractions with oligo(dT) and RNaseH [poly(A)– RNA fraction]. The RNase H enzyme hydrolyzes the 3'-terminal phosphodiester bonds of RNA hybridized to DNA. This resulted in a dramatic decrease in the length of snRNAs (Fig. 7A to E, right panels, lanes 17 and 18). These data indicate that the overexpressed DmTRF4-1 catalyzes the extraordinary polyadenylation of snRNAs and that the abnormally polyadenylated snRNAs by overexpression of DmTRF4-1 are digested in a DmRrp6-dependent manner. In contrast, no aberrant polyadenylation of snRNAs was detectable in the poly(A)+ RNA fraction from the other flies (Fig. 7A to E, middle panels, lanes 7 to 10), whereas snRNAs were abundant in the total RNA fractions. This is probably because the polyadenylated snRNAs were subject to immediate degradation under normal conditions. Several reports indicate that noncoding RNAs and tRNAs are targets for polyadenylation by Saccharomyces cerevisiae Trf4 (9, 21, 25, 43, 53). Thus, we also tested the polyadenylation of several kinds of snoRNAs and tRNAs. However, no signal could be detected in the present study (data not shown).
|
|
|---|
Our experiments suggest that DmTRF4-1 is localized in the nucleoli and reveal that overexpression of DmTRF4-1 induces an extraordinary polyadenylation of snRNAs. Recently, Cid14 was identified as a nucleolar protein (51). Furthermore, it was reported that polyadenylated RNAs accumulate in the nucleoli of yeast cells lacking either Rrp6 or Mtr4 (4), suggesting that polyadenylation-dependent exosome-mediated degradation mainly occurs in nucleoli. In addition, it has been found that the vertebrate snRNAs are transiently transferred to the nucleoli (12, 26), where snRNAs undergo common internal modification, including pseudouridylation and 2'-O-methylation (54). These observations suggest that DmTRF4-1 catalyzes polyadenylation of snRNAs in the nucleoli, where snRNAs are exposed to posttranscriptional modification.
We found that overexpression of DmTRF4-1 in the eye disc causes the rough eye phenotype, which is partially rescued by the suppression of Rrp6. This phenotype might result from abnormal degradation of the polyadenylated snRNAs caused by constitutive overexpression of DmTRF4-1, leading to disruption of normal RNA splicing. Suppression of DmRrp6 might moderate the rough eye phenotype by inhibiting the degradation of the polyadenylated snRNAs, although it is unclear whether the polyadenylated snRNAs retain a normal function. We detected polyadenylated snRNAs only in the DmTRF4-1-overexpressing background, probably because the rate of polyadenylation by overexpressed DmTRF4-1 exceeds that of DmRrp6-mediated degradation. Unfortunately, we could not examine the polyadenylation of snRNAs using the DmRrp6 null mutant because DmRrp6 is an essential gene in Drosophila. However, enhanced accumulation of polyadenylated snRNAs in the DmTRF4-1 overexpressing and heterozygous DmRrp6f07001 background suggests that the snRNAs polyadenylated by DmTRF4-1 are digested in the DmRrp6-dependent pathway. In contrast, we could not detect polyadenylation of snoRNAs and tRNAs even under conditions where the transcription of DmTRF4-1 was stimulated. In yeast, the elongated RNAs were detectable only in the rrp6-null mutant. Polyadenylation was tested by transient overexpression of DmTRF4-1 using the Hsp-GAL4 driver. We cannot rule out the possibility that these noncoding RNAs and tRNAs are targets of polyadenylation catalyzed by DmTRF4-1 under normal conditions. Therefore, ubiquitous overexpression of DmTRF4-1 might cause an abnormal polyadenylation of RNAs other than snRNAs that could not be detected by the transient overexpression. Such polyadenylation might lead to the rough eye phenotype.
Trf4 and GLD-2 proteins are often considered as a single family. However, we propose these proteins should be classified into two distinct families; the nuclear/nucleolar noncanonical PAP family and the cytoplasmic noncanonical PAP family. In fact, it seems more likely that each member is conserved, respectively, in eukaryotes, except S. cerevisiae, in which the candidate gene of cytoplasmic noncanonical PAP, as a homologue of GLD-2, does not exist (40). Indeed, a homology search of the Drosophila genome sequence database shows CG5732 and CG15737 are similar to GLD-2 (data not shown). Thus, we speculate that CG5732 and/or CG15737 may play a role as a cytoplasmic noncanonical PAP. We suggest that various PAPs, including the Trf4 family, GLD-2 family, mitochondrial PAP and nuclear canonical PAP, play important roles in diverse biological processes, in different cellular locations.
Here, we focused on the function of DmTRF4-1 in RNA surveillance. However, a previous study using two-hybrid screening showed that DmTRF4-1 (CG11265) might interact with several components of the Hedgehog signaling (Hh) pathway, including suppressor of fused protein and kinesin-like protein Costal2 (10). The Hh signaling pathway is important for development, which regulate the transcription of specific target genes, resulting in the control of growth and differentiation (17, 38). Therefore, it is possible that DmTRF4-1 might participate not only in an RNA quality control but also in the Hh pathway, although we have never tested whether this protein interacts with the Hh factors.
In summary, we identified the Drosophila homologues of ScTrf4/5, named DmTRF4-1 and DmTRF4-2. Only DmTRF4-1 possesses PAP activity, and both the DmTRF4-1 knockdown and the overexpressing mutants were inviable, suggesting that transcription of this gene must be strictly regulated for development. DmTRF4-1 is localized in nucleoli, and the overexpression of DmTRF4-1 induced an extraordinary polyadenylation of snRNAs. Moreover, enhanced accumulation of the polyadenylated snRNAs was observed by suppression of DmRrp6. From these data, we suggest that DmTRF4-1 plays an important role in the regulation of RNA quality in vivo.
Published ahead of print on 2 September 2008. ![]()
|
|
|---|
5' exoribonucleases. Cell 91:457-466.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»